Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) was the recipient of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 86,700 shares, a growth of 181.5% from the February 13th total of 30,800 shares. Based on an average daily volume of 219,900 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.4% of the company's shares are sold short.
Entera Bio Stock Down 5.0 %
Shares of ENTX traded down $0.06 during trading hours on Friday, reaching $1.15. 180,251 shares of the company traded hands, compared to its average volume of 288,118. Entera Bio has a 12-month low of $0.47 and a 12-month high of $3.00. The stock's fifty day moving average price is $0.95 and its 200 day moving average price is $0.93.
Get Entera Bio alerts:Institutional Trading of Entera Bio
A number of large investors have recently made changes to their positions in the stock. Renaissance Technologies LLC raised its holdings in shares of Entera Bio by 555.4% in the fourth quarter. Renaissance Technologies LLC now owns 139,600 shares of the company's stock valued at $102,000 after acquiring an additional 118,300 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Entera Bio by 358.5% in the fourth quarter. Millennium Management LLC now owns 46,000 shares of the company's stock valued at $34,000 after acquiring an additional 35,968 shares in the last quarter. Finally, PNC Financial Services Group Inc. bought a new stake in shares of Entera Bio in the first quarter valued at about $29,000. 20.12% of the stock is owned by hedge funds and other institutional investors.
About Entera Bio
(Get Rating)
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Featured Stories
- Get a free copy of the StockNews.com research report on Entera Bio (ENTX)
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
Receive News & Ratings for Entera Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entera Bio and related companies with MarketBeat.com's FREE daily email newsletter.
